Cleveland BioLabs (CBLI) Announces Quarterly Earnings Results
Cleveland BioLabs (NASDAQ:CBLI) issued its quarterly earnings data on Thursday. The company reported ($0.09) earnings per share (EPS) for the quarter, American Banking News reports.
Shares of Cleveland BioLabs (NASDAQ:CBLI) traded down 4.95% on Thursday, hitting $0.3802. 167,688 shares of the company’s stock traded hands. Cleveland BioLabs has a 52-week low of $0.40 and a 52-week high of $1.84. The stock’s 50-day moving average is $0.48 and its 200-day moving average is $0.61. The company’s market cap is $19.4 million.
Cleveland BioLabs, Inc (NASDAQ:CBLI), incorporated on June 5 2003, is a biotechnology company focused on developing biodefense, tissue protection and cancer treatment drugs based on the concept of modulation of cell death for therapeutic benefit.
Receive News & Ratings for Cleveland BioLabs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cleveland BioLabs and related companies with Analyst Ratings Network's FREE daily email newsletter.